Not Tagged
Not Tagged
['leusm']
 presents on ph i dose escalation of anti-cd22 adc (adct-602) monotx in adults w/ r/r b-all (allowed inotuz as long as &gt;3m prior). 24 enrolled pts to date, median 5 prior tx, initially q3w (n=11) -&gt; then changed to weekly (n=13) based on pk. 1/2 #ash22 #leusm #allsm 
Leukemia/cell therapy doc & AYA Leukemia Program Leader at @MSKCancerCenter w/ special interest in ALL. Indie rock & Boston sports fan. Opinions=my own.??????